Kossan Rubber Industries Bhd (KSRBF)
USD 0.34
(26.19%)
USD 0.34
(26.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.25 Billion MYR | 0.83% |
| 2022 | -1.26 Billion MYR | 45.17% |
| 2021 | -2.3 Billion MYR | -344.46% |
| 2020 | -518.82 Million MYR | -224.76% |
| 2019 | 415.86 Million MYR | 14.76% |
| 2018 | 362.36 Million MYR | 94.44% |
| 2017 | 186.36 Million MYR | 175.53% |
| 2016 | 67.63 Million MYR | 23.18% |
| 2015 | 54.9 Million MYR | -61.39% |
| 2014 | 142.19 Million MYR | 107.98% |
| 2013 | 68.37 Million MYR | -31.05% |
| 2012 | 99.15 Million MYR | -8.48% |
| 2011 | 108.33 Million MYR | 25.62% |
| 2010 | 86.24 Million MYR | -52.94% |
| 2009 | 183.28 Million MYR | -13.19% |
| 2008 | 211.12 Million MYR | 33.42% |
| 2007 | 158.23 Million MYR | 8.37% |
| 2006 | 146.01 Million MYR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.26 Billion MYR | 2.88% |
| 2024 Q1 | -1.3 Billion MYR | -4.22% |
| 2023 Q2 | -1.19 Billion MYR | 1.67% |
| 2023 Q1 | -1.21 Billion MYR | 3.78% |
| 2023 Q4 | -1.25 Billion MYR | -1.42% |
| 2023 Q3 | -1.23 Billion MYR | -3.34% |
| 2023 FY | -1.25 Billion MYR | 0.83% |
| 2022 Q4 | -1.26 Billion MYR | -6.2% |
| 2022 Q2 | -1.22 Billion MYR | 15.79% |
| 2022 Q1 | -1.45 Billion MYR | 36.98% |
| 2022 FY | -1.26 Billion MYR | 45.17% |
| 2022 Q3 | -1.19 Billion MYR | 2.7% |
| 2021 Q3 | -2.38 Billion MYR | -47.04% |
| 2021 Q4 | -2.3 Billion MYR | 3.41% |
| 2021 Q1 | -753.58 Million MYR | -45.25% |
| 2021 FY | -2.3 Billion MYR | -344.46% |
| 2021 Q2 | -1.62 Billion MYR | -115.45% |
| 2020 Q3 | -262.06 Million MYR | -228.21% |
| 2020 Q1 | 431.92 Million MYR | 3.86% |
| 2020 Q2 | 204.4 Million MYR | -52.68% |
| 2020 Q4 | -518.82 Million MYR | -97.98% |
| 2020 FY | -518.82 Million MYR | -224.76% |
| 2019 FY | 415.86 Million MYR | 14.76% |
| 2019 Q4 | 415.86 Million MYR | -1.12% |
| 2019 Q1 | 413.63 Million MYR | 14.15% |
| 2019 Q2 | 439.86 Million MYR | 6.34% |
| 2019 Q3 | 420.58 Million MYR | -4.38% |
| 2018 Q4 | 362.36 Million MYR | 1.32% |
| 2018 Q3 | 357.65 Million MYR | 22.28% |
| 2018 Q1 | 272.65 Million MYR | 46.3% |
| 2018 FY | 362.36 Million MYR | 94.44% |
| 2018 Q2 | 292.48 Million MYR | 7.27% |
| 2017 Q1 | 129.93 Million MYR | 92.1% |
| 2017 FY | 186.36 Million MYR | 175.53% |
| 2017 Q4 | 186.36 Million MYR | 20.76% |
| 2017 Q3 | 154.32 Million MYR | 32.25% |
| 2017 Q2 | 116.69 Million MYR | -10.19% |
| 2016 Q1 | 38.76 Million MYR | -29.4% |
| 2016 FY | 67.63 Million MYR | 23.18% |
| 2016 Q2 | 10.22 Million MYR | -73.62% |
| 2016 Q3 | 65.77 Million MYR | 543.25% |
| 2016 Q4 | 67.63 Million MYR | 2.84% |
| 2015 Q2 | 140 Million MYR | -17.45% |
| 2015 Q3 | 123.93 Million MYR | -11.48% |
| 2015 Q4 | 54.9 Million MYR | -55.69% |
| 2015 FY | 54.9 Million MYR | -61.39% |
| 2015 Q1 | 169.59 Million MYR | 19.27% |
| 2014 Q4 | 142.19 Million MYR | 23.76% |
| 2014 Q1 | 108.67 Million MYR | 58.95% |
| 2014 Q3 | 114.9 Million MYR | 5.27% |
| 2014 Q2 | 109.15 Million MYR | 0.44% |
| 2014 FY | 142.19 Million MYR | 107.98% |
| 2013 Q1 | 75.9 Million MYR | -23.45% |
| 2013 FY | 68.37 Million MYR | -31.05% |
| 2013 Q4 | 68.37 Million MYR | -20.71% |
| 2013 Q3 | 86.22 Million MYR | 87.25% |
| 2013 Q2 | 46.04 Million MYR | -39.34% |
| 2012 Q3 | 96.42 Million MYR | -13.62% |
| 2012 FY | 99.15 Million MYR | -8.48% |
| 2012 Q2 | 111.63 Million MYR | 19.14% |
| 2012 Q4 | 99.15 Million MYR | 2.83% |
| 2012 Q1 | 93.7 Million MYR | 0.0% |
| 2011 FY | 108.33 Million MYR | 25.62% |
| 2010 FY | 86.24 Million MYR | -52.94% |
| 2009 FY | 183.28 Million MYR | -13.19% |
| 2008 FY | 211.12 Million MYR | 33.42% |
| 2007 FY | 158.23 Million MYR | 8.37% |
| 2006 FY | 146.01 Million MYR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 261547.863% |
| Ansell Limited | -54.99 Million USD | -2180.102% |
| Ansell Limited | -55.1 Million USD | -2175.835% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | -3336.219% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -1193012.405% |
| Psykey, Inc. | 634.59 Thousand USD | 197704.606% |
| ConvaTec Group Plc | 1.2 Billion USD | 204.446% |
| ConvaTec Group Plc | 1.2 Billion USD | 204.299% |
| Encision Inc. | 1.29 Million USD | 97255.946% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 54415.232% |
| Innovative MedTech Inc. | 1.76 Million USD | 71157.937% |
| LifePoint, Inc. | -3.26 Million USD | -38318.411% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 25669.708% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 58101.156% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -2895671.753% |
| Reflect Scientific, Inc. | -1.03 Million USD | -121022.044% |
| SmileDirectClub, Inc. | 778.67 Million USD | 261.04% |
| Sector 10, Inc. | 163 Thousand USD | 769415.951% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | -200.317% |
| SheerVision, Inc. | 57.34 Thousand USD | 2186685.642% |
| United Health Products, Inc. | 660.56 Thousand USD | 189934.067% |
| Vasamed, Inc. | 22.12 Thousand USD | 5668597.423% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 47757.949% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 162474.608% |